March 28, 2017
Recommended Topic Related To:

Lynparza

"Another study shows that a "liquid biopsy" that measures levels of circulating tumor DNA (ctDNA) can be useful for monitoring cancer patients “ this time patients with ovarian cancer.

At a recent cancer research meeting, experts predi"...

A A A

Lynparza

LYNPARZA™
(olaparib) Capsules

DRUG DESCRIPTION

Olaparib is an inhibitor of the mammalian polyadenosine 5’-diphosphoribose polymerase (PARP) enzyme.

The chemical name is 4-[(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]phthalazin-1(2H)one and it has the following chemical structure:

LYNPARZA™ (olaparib) Structural Formula Illustration

The empirical molecular formula for Lynparza is C24H23FN4O3 and the relative molecular mass is 434.46.

Olaparib is a crystalline solid, is non-chiral and shows pH-independent low solubility of approximately 0.1 mg/mL across the physiological pH range.

Lynparza is available in 50 mg capsules for oral administration. Each capsule contains olaparib as the active ingredient and the following inactive ingredients:

  • Capsule content: lauroyl polyoxylglycerides
  • Capsule shell: hypromellose, titanium dioxide, gellan gum, potassium acetate
  • Capsule printing ink: shellac, ferrosoferric oxide

Last reviewed on RxList: 2/9/2017
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.